Your browser doesn't support javascript.
loading
Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis.
Su, Xin; Zhao, Xin; Deng, Jia-Long; Li, Song-Nan; Du, Xin; Dong, Jian-Zeng; Ma, Chang-Sheng.
Afiliación
  • Su X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China.
  • Zhao X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China.
  • Deng JL; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China.
  • Li SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China.
  • Du X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China.
  • Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China.
  • Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China.
J Viral Hepat ; 28(4): 664-671, 2021 04.
Article en En | MEDLINE | ID: mdl-33452699

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepatitis C / Hepatitis C Crónica Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepatitis C / Hepatitis C Crónica Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China